Latest News
23-Jan-2026 New Drugs Could Hit Market Sooner
22-Jan-2026 DRL to Launch Generic Version of Novo’s Semaglutide in March
21-Jan-2026 Novo Nordisk Parent Acquires 49% Stake in Surya Hospitals
19-Jan-2026 Sun Pharma Looks to Rise in US with $10-b Organon Buy
19-Jan-2026 Health Min Seeks ‘Workable Solution’ to Schedule M Issue
  more...
Latest Reports
Jan-26 Pharma Weekender – In case you missed it - Emkay Research  
Jan-26 Pharma Weekender– In case you missed it - Emkay Research  
Jan-26 Q3FY26–Seasonality to hit hospitals - Emkay Research  
Jan-26 Base business momentum to offset gRevlimid drag - HDFC Securities  
Jan-26 Indian CRDMOs at a pivotal point; scale-up key - HDFC Securities  
  more...

Quarterly Summary September-2025
Desc Current Previous Per.Chg
Sales 69704.5 69535.4 0.2
Otherincome 3582.4 2652.8 35.0
Expense 54109.9 51586.9 4.9
RawMaterial 20222.3 19756.9 2.4
StaffCost 11464.9 10460.1 9.6
ExciseDuty 17.0 8.8 93.2
OtherExp 16066.7 15807.9 1.6
Interest 1339.9 1160.6 15.5
GrossProfit 19362.6 20742.2 -6.7
Depreciation 3085.3 2813.3 9.7
Tax 3536.7 4195.0 -15.7
NetProfit 12267.1 13807.6 -11.2
Total.Comp 189 -- --
Source: ETIG Database

Sectoral Companies As on 23 Jan 2026
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 391481.78
Divi's Lab 159404.05
Torrent Phar 132903.70
Cipla 106207.01
Dr.Reddy's 103085.62
Lupin 97625.01
Zydus Life 88741.81
Mankind Phar 86801.52
Alkem Labora 68693.43
Aurobindo Ph 66391.26
Abbott (I) 59138.43
Glenmark Pha 55614.57
Biocon 55261.91
  click here for the complete list